Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

• Status: Completed
• Trial end date: 2008-07-22

Summary

A study to evaluate the effect of SB-656933-AAA on the body after a single dose in subjects who have been challenged with ozone.

• Phase: Phase 1

Details

• Lead Sponsor: GlaxoSmithKline